In this proof-of-concept study, bedaquiline therapy cleared Mycobacterium leprae by four weeks of treatment in patients with ...

QIAGEN has filed a lawsuit against bioMérieux in the German Unified Patent Court to protect its QuantiFERON technology, specifically its Europea ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has filed a complaint against bioMérieux S.A.

IAVI and Biofabri are collaborating on the trial, which will recruit around 4,300 patients with latent TB infections across ...

Spreading easily through the air, Mycobacterium tuberculosis can establish a chronic infection in human lungs, which can turn ...

Working towards more effective tuberculosis (TB) vaccinations, researchers at Weill Cornell Medicine have developed two ...

Seventeen Oxford University researchers have been awarded £5 million to develop new therapies for drug-resistant tuberculosis.

In a concerning development, two female elephants at Karachi’s Safari Park, Malaika and Madhubala, have been diagnosed with ...

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill ...